Tag | Content |
---|
EnhancerAtlas ID | HS182-03879 |
Organism | Homo sapiens |
Tissue/cell | Spleen |
Coordinate | chr11:64538900-64540900 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
ALX3 | MA0634.1 | chr11:64540118-64540128 | TCTAATTAAA | + | 6.02 | ALX3 | MA0634.1 | chr11:64540754-64540764 | TCTAATTAAA | + | 6.02 | JUN | MA0488.1 | chr11:64539980-64539993 | ATTACATCATCTT | - | 6.82 | JUND(var.2) | MA0492.1 | chr11:64539979-64539994 | CATTACATCATCTTC | - | 6.02 |
|
| Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
SE_10842 | chr11:64538071-64541772 | CD19_Primary | SE_62643 | chr11:64529289-64571988 | Tonsil |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 2 | Chromosome | Start | End |
chr11 | 64539200 | 64540400 | chr11 | 64539354 | 64539831 |
|
| Number: 1 | ID | Chromosome | Start | End |
GH11I064771 | chr11 | 64538891 | 64541493 |
|
Enhancer Sequence | AAAAAACATA CTGAAAGTAA TCAAGACTCC TATACCCTTG GTTTAGTTGA GAGAACCTTG 60 CCTAGTTGGA GAGCAAGGAC TGAACTCGGC TGCTCCCACT GTCTTCAGCC TAAAGGGAAC 120 CATGTCACAC CACGTTACAC ACACGATGGA ATAAAAGGTC AGGTTTGTTC ATGGCTAATG 180 ACGGCTAAAT GACACCTCCG TTTCTAGCAT TTGTATAAAC TGTTAGCACA ATCCATTAAG 240 AGTGAACAAA AGCAAACATA CCCCAGCTCA TTAGACTACC ATCTTATACA TTTAAGTCTA 300 CAAGAAAAGT TTTAAACATG TTTTTACTGT GCAAGTTAAG CAGCATCAAA ATAACAATAA 360 AGTGGCTTAA GTGATATAAC ACCTTTTTAA GAAATTATCT TAATTAAGAA AACCCATGCA 420 TTTCCCTCCA ACCTGGGCTC AAAAGCAAAA CCAATCAGGC ATTAGGGCCT CTTTCAAAAC 480 TGAATAGAAG GGAGGAAAAA CCCTGCTCTG GTTTTATTTC TAACATGCTT GACATTTCTA 540 ATTCCCACCC CACAGCTGTC TAGAATTAAG CATTCTTAGC TAGTTACAAA AACAAGTCTT 600 ACCAGCACCC AATTGGCCAT GTGAAGGCCT CACAACAGTT TAACCTCCTC CCAAATTGCA 660 GAAGTGAAAG GCAAAAGCTA GTATTCTAGA GGTTAGACTG GCCCGACTTC TTCACCTCCA 720 ACAGGCATCG GCTAGATCAA CTAAATTCTA ATCCCAGTTA TCCAGGAAGC AAAGAAGGTT 780 TGTTAAAAAT TCAACCTTTG GAGGAATTGA CTGGTGACCT GTAGACATAT TATTAAAGGG 840 AAAAAGGCCA AAAAGGCACT AAACAGTTGT GGTCTATGAC CTACAATGTA AATTTAAAAA 900 AAAAAAAAAT CTTCAAAAAG AAACGAAACA CAACACAACC CTACAACCAA AATCTATCTA 960 TAGGTAAAAT ATAGCAAATG TAGTAAGTCA AATTAAAGAG TCAATATGGA GAAACAAGGA 1020 AGTTAATGTT TCCTGGCAAA GGGCGGAAGA AAGATGCATG AGTGAGTGAC TTCTAAAGCC 1080 ATTACATCAT CTTCCTGATT TAATAAGCTA TTAACTGGGT AACAAAAACC AAAAACACTA 1140 CTTTTTAAAG CAAAGTCTTT TCAACTATTC TGTATGTACT AAGAGAAAAT TCAGTGAGAG 1200 GGAGAGACTT ACTGCCCTTC TAATTAAATG ACCAATTTTA GCTGTTCAAT CAGCTAATAA 1260 AATTCCAGTT TAAAAAAGTT CATCTCCCCC ACACAATTTA TTTTTCTGAG GTGAGAGAAA 1320 CTGCAAACTG AAATGACATG ACCACAGCTG TTTGAGGCCC ACGCTCCCTT TAAGGAAAAA 1380 AAAAAAGTAA TTTAGGGTTG GTTGCATGCC TTCCCAAAAT AGGTGAGAAT ATTCTGGCCC 1440 CTCCCAACAC CCCCAAGGCA ATGGCCAAGG CTGAAAGTTA ACTGGCAGTG AAAGAAGTTG 1500 GTTAGAAATC TCATCTGATT TTGAAACCAT CTCAAAACCA TGAGCAGGAA GACTGCAGCA 1560 ATGAGCTGAC CAGAGCTCCT GGCTTGCTCA AGTTCAGTGA TGCTCAAAAA TATTTTTAGT 1620 CCCTGCACTG TGTACCTGTG AGAAAAACTC TATGCCCTGG GCTTTTGGCC AAAGCAGGTA 1680 CTGAAAAGGC AGGTTAACGG GCCACCTCAC TGTCCCCTAA GGGTGGGTAA ATCAGGTTAA 1740 GATCTACATG CTTACCAATT GGAAACCAGT TGTCCATTTT CCTGTAACTT TTTATTCTCC 1800 CAACATTTTT AAGTTTTATT CCAATTTTCT AACTGTTGAC TGACCATACA TATTTCTAAT 1860 TAAACCTTAA TCCCCAAAGT GGTCAGGGTA CAGTCGTCAT ACTATGATTT TATTGAACTG 1920 ACACAATATG TTGCCACCAG TAAAACGTAT TGAGAAAAAG GTAAAAGCGT TACTGTCAGC 1980 TGGTTAAAAC TGTTTCCCAA 2000
|